Figure 2.
Forest plot of the standardized mean difference (SMD) with 95% confidence intervals (CI) for mosapride combined with PPI versus PPI alone for gastroesophageal reflux disease. (A): Symptom score change. (B): Symptom score after treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.